Appropriate Treatment Intensity for Diffuse Large B-Cell Lymphoma in the Older Population: A Review of the Literature
Hematology Reports · 24.05.2024 · 16 (2) · 317-330
DOI: 10.3390/hematolrep16020032 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hematology Reports, online erschienen am 24.05.2024. Verfasst von Satoshi Yamasaki. Beteiligte Einrichtung: Department of Hematology, St. Mary's Hospital, 422 Tsubukuhonmachi, Kurume 830-8543, Japan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Most patients with diffuse large B-cell lymphoma (DLBCL) are >65 years of age, with the number of patients expected to increase in the coming years. A comprehensive geriatric assessment that carefully evaluates fitness status and comorbidities is essential for selecting the appropriate treatment intensity. Although generally healthy patients or those 80 years old may require reduced-intensity chemotherapy or less-toxic drugs. Some new drugs are currently being tested as single or combined agents for first-line treatment, aiming to improve the outcomes of conventional chemotherapy. This review systematically collates and discusses the outcomes associated with the use of immunochemotherapy in older patients with DLBCL, as well as considering the impact of full-dose immunochemotherapy on quality of life in older and frail patients, summarizing the rationale for reduced dosing in the older population, and presenting recommendations for selecting patients likely to benefit from reduced dosing. If preliminary efficacy and safety data are confirmed in future clinical trials, non-chemotherapy-based immunotherapy approaches could become an alternative potentially curative option in frail patients and those >80 years of age with DLBCL.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, St. Mary's Hospital, 422 Tsubukuhonmachi, Kurume 830-8543, Japan.
- Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu 874-0838, Japan.
- Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka 810-0065, Japan.
ORCID-Profile: Satoshi Yamasaki
Förderung
- JSPS KAKENHI
Zitieren
APA
Yamasaki, S. (2024). Appropriate Treatment Intensity for Diffuse Large B-Cell Lymphoma in the Older Population: A Review of the Literature. Hematology Reports, 16(2), 317-330. https://doi.org/10.3390/hematolrep16020032
Vancouver
Yamasaki S. Appropriate Treatment Intensity for Diffuse Large B-Cell Lymphoma in the Older Population: A Review of the Literature. Hematology Reports. 2024;16(2):317-330. doi:10.3390/hematolrep16020032
BibTeX
@article{Yamasaki2024,
author = {Yamasaki, Satoshi},
title = {Appropriate Treatment Intensity for Diffuse Large B-Cell Lymphoma in the Older Population: A Review of the Literature},
journal = {Hematology Reports},
year = {2024},
volume = {16},
number = {2},
pages = {317--330},
doi = {10.3390/hematolrep16020032}
}
EUVIMED